Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.

doi:10.1371/journal.pone.0166998

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.

PloS one - 1 Jan 2016

Aiken Taylor, Garber Ari, Thomas Dawn, Hamon Nicole, Lopez Rocio, Konjeti Rajesh, McCullough Arthur, Zein Nizar, Fung John, Askar Medhat, John Binu V

Abstract excerpt

BACKGROUND AND AIMS: Early post-transplant hepatic fibrosis is associated with poor outcomes and may be influenced by donor/recipient genetic factors. The rs368234815 IFNL4 polymorphism is related to the previously described IL28B polymorphism, which predicts etiology-independent hepatic fibrosis. The aim of this study was to identify the impact of donor and/or recipient IFNL4 genotype on early fibrosis among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Hepatitis C, Chronic

Share to Interleukins

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Survival Rate

Share to Tissue Donors

Source

Open in PubMed Open full text

Identifiers

PMID: 27875564
DOI: 10.1371/journal.pone.0166998
PMCID: PMC5119817

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.PMID 27875564Read ↗

IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.Semantic proximity Read ↗

The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.Semantic proximity Read ↗

Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.Semantic proximity Read ↗

Hepatitis C genotype influences post-liver transplant outcomes.Semantic proximity Read ↗

Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C.Semantic proximity Read ↗

Impact of Donor and Recipient Single Nucleotide Polymorphisms in Living Liver Donor Transplantation for Hepatitis C.Semantic proximity Read ↗

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease.Semantic proximity Read ↗

Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection.Semantic proximity Read ↗

Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers.Semantic proximity Read ↗

A single nucleotide polymorphism of Toll-like receptor 4 identifies the risk of developing graft failure after liver transplantation.Semantic proximity Read ↗

The Impact of Donor Liver Fibrosis on the Outcomes of Patients Who Undergo Liver Transplant: A Cohort Study from Unos DatabaseSemantic proximity Read ↗

Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.